Free Trial

JFrog (FROG) Financials

JFrog logo
$64.62 +0.45 (+0.69%)
As of 03:43 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for JFrog

Annual Income Statements for JFrog

This table shows JFrog's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-26 -5.39 -9.41 -64 -90 -61 -69 -72
Consolidated Net Income / (Loss)
-26 -5.39 -9.41 -64 -90 -61 -69 -72
Net Income / (Loss) Continuing Operations
-26 -5.39 -9.41 -64 -90 -61 -69 -72
Total Pre-Tax Income
-26 -3.77 -12 -68 -85 -55 -66 -66
Total Operating Income
-27 -6.94 -14 -68 -90 -76 -91 -92
Total Gross Profit
53 85 122 165 218 273 330 408
Total Revenue
64 105 151 207 280 350 428 532
Operating Revenue
64 105 151 207 280 350 428 532
Total Cost of Revenue
11 20 28 42 62 77 98 123
Operating Cost of Revenue
11 20 28 42 62 77 98 123
Total Operating Expenses
80 92 137 233 308 348 421 500
Selling, General & Admin Expense
19 18 35 57 56 63 70 81
Marketing Expense
35 44 61 97 131 151 190 224
Research & Development Expense
26 30 41 80 121 135 161 195
Total Other Income / (Expense), net
1.31 3.17 2.05 0.74 5.09 21 25 26
Other Income / (Expense), net
1.31 3.17 2.05 0.74 5.09 21 25 26
Income Tax Expense
0.47 1.63 -2.74 -3.42 5.44 6.74 3.42 5.78
Basic Earnings per Share
($1.00) ($0.20) ($0.20) ($0.68) ($0.91) ($0.59) ($0.63) ($0.62)
Weighted Average Basic Shares Outstanding
26.10M 27.13M 46.49M 94.78M 99.24M 103.32M 109.69M 116.20M
Diluted Earnings per Share
($1.00) ($0.20) ($0.20) ($0.68) ($0.91) ($0.59) ($0.63) ($0.62)
Weighted Average Diluted Shares Outstanding
26.10M 27.13M 46.49M 94.78M 99.24M 103.32M 109.69M 116.20M
Weighted Average Basic & Diluted Shares Outstanding
26.10M 27.13M 46.49M 94.78M 100.95M 106.31M 112.88M 119.63M
Cash Dividends to Common per Share
- - $0.00 $0.00 - - $0.00 $0.00

Quarterly Income Statements for JFrog

This table shows JFrog's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-14 -11 -8.79 -14 -23 -23 -19 -22 -16 -15 -8.27
Consolidated Net Income / (Loss)
-14 -11 -8.79 -14 -23 -23 -19 -22 -16 -15 -8.27
Net Income / (Loss) Continuing Operations
-14 -11 -8.79 -14 -23 -23 -19 -22 -16 -15 -8.27
Total Pre-Tax Income
-12 -8.97 -9.55 -12 -24 -20 -17 -20 -15 -14 -5.78
Total Operating Income
-18 -15 -17 -19 -30 -25 -23 -26 -22 -21 -13
Total Gross Profit
69 77 80 81 82 88 92 97 106 113 120
Total Revenue
89 97 100 103 109 116 122 127 137 145 154
Operating Revenue
89 97 100 103 109 116 122 127 137 145 154
Total Cost of Revenue
20 20 21 22 27 29 30 30 31 32 34
Operating Cost of Revenue
20 20 21 22 27 29 30 30 31 32 34
Total Operating Expenses
87 92 96 100 112 113 115 123 128 134 133
Selling, General & Admin Expense
16 18 17 17 18 18 19 20 20 22 24
Marketing Expense
38 41 44 46 51 50 53 55 56 60 58
Research & Development Expense
33 33 36 37 43 45 43 47 51 53 52
Total Other Income / (Expense), net
5.73 6.41 7.09 6.90 5.71 5.59 5.97 6.31 6.68 6.87 7.15
Other Income / (Expense), net
5.73 6.41 7.09 6.90 5.71 5.59 5.97 6.31 6.68 6.87 7.15
Income Tax Expense
1.43 2.27 -0.76 2.07 -1.27 3.37 1.50 2.01 1.52 0.76 2.49
Basic Earnings per Share
($0.13) ($0.10) ($0.08) ($0.13) ($0.21) ($0.21) ($0.16) ($0.19) ($0.14) ($0.13) ($0.07)
Weighted Average Basic Shares Outstanding
104.13M 103.32M 107.03M 108.94M 110.77M 109.69M 113.45M 115.25M 117.26M 116.20M 120.16M
Diluted Earnings per Share
($0.13) ($0.10) ($0.08) ($0.13) ($0.21) ($0.21) ($0.16) ($0.19) ($0.14) ($0.13) ($0.07)
Weighted Average Diluted Shares Outstanding
104.13M 103.32M 107.03M 108.94M 110.77M 109.69M 113.45M 115.25M 117.26M 116.20M 120.16M
Weighted Average Basic & Diluted Shares Outstanding
104.89M 106.31M 108.42M 110.42M 111.56M 112.88M 114.57M 116.74M 118.31M 119.63M 121.12M

Annual Cash Flow Statements for JFrog

This table details how cash moves in and out of JFrog's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
120 -139 124 -96 -23 39 -34 26
Net Cash From Operating Activities
8.56 10 29 28 21 74 111 146
Net Cash From Continuing Operating Activities
8.56 10 29 28 21 74 111 146
Net Income / (Loss) Continuing Operations
-26 -5.39 -9.41 -64 -90 -61 -69 -72
Consolidated Net Income / (Loss)
-26 -5.39 -9.41 -64 -90 -61 -69 -72
Depreciation Expense
1.12 2.81 3.66 8.75 15 15 21 25
Amortization Expense
0.00 -0.37 1.91 5.52 2.35 -6.41 -6.57 -5.24
Non-Cash Adjustments To Reconcile Net Income
20 9.37 24 63 78 103 140 165
Changes in Operating Assets and Liabilities, net
13 3.59 9.45 15 17 23 25 33
Net Cash From Investing Activities
-3.08 -150 -312 -126 -53 -53 -165 -152
Net Cash From Continuing Investing Activities
-3.08 -150 -312 -126 -53 -53 -165 -152
Purchase of Property, Plant & Equipment
-2.08 -1.80 -3.52 -4.23 -4.33 -1.98 -3.14 -3.46
Acquisitions
-1.00 -21 0.00 -196 -0.48 0.00 -157 0.00
Purchase of Investments
0.00 -203 -451 -266 -411 -392 -514 -626
Sale and/or Maturity of Investments
0.00 77 142 341 363 341 508 477
Net Cash From Financing Activities
114 0.74 406 1.44 11 18 21 31
Net Cash From Continuing Financing Activities
114 0.74 406 1.44 11 18 21 31
Issuance of Common Equity
0.00 -0.19 393 3.09 5.18 6.67 8.74 12
Other Financing Activities, net
0.52 0.93 13 -1.65 5.85 12 12 19
Effect of Exchange Rate Changes
- - 0.00 0.00 -2.05 0.12 -0.95 1.25

Quarterly Cash Flow Statements for JFrog

This table details how cash moves in and out of JFrog's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
14 24 -13 147 -155 -12 -5.52 6.93 27 -2.56 -15
Net Cash From Operating Activities
26 33 17 17 28 49 29 36 30 51 38
Net Cash From Continuing Operating Activities
26 33 17 17 28 49 29 36 30 51 38
Net Income / (Loss) Continuing Operations
-14 -11 -8.79 -14 -23 -23 -19 -22 -16 -15 -8.27
Consolidated Net Income / (Loss)
-14 -11 -8.79 -14 -23 -23 -19 -22 -16 -15 -8.27
Depreciation Expense
3.84 3.79 3.80 3.83 6.98 6.86 6.71 6.56 5.66 5.57 5.56
Amortization Expense
-1.72 -1.82 -2.01 -1.74 -1.39 -1.43 -1.56 -1.47 -1.17 -1.04 -0.92
Non-Cash Adjustments To Reconcile Net Income
28 31 30 31 39 41 39 40 43 43 42
Changes in Operating Assets and Liabilities, net
10 11 -5.18 -1.96 6.49 26 3.26 13 -0.58 18 0.37
Net Cash From Investing Activities
-16 -16 -47 135 -188 -66 -46 -40 -11 -56 -53
Net Cash From Continuing Investing Activities
-16 -16 -47 135 -188 -66 -46 -40 -11 -56 -53
Purchase of Property, Plant & Equipment
-0.59 -0.62 -0.84 -0.73 -0.94 -0.63 -0.65 -0.63 -1.35 -0.84 -1.07
Purchase of Investments
-99 -89 -165 -91 -124 -134 -149 -135 -159 -183 -166
Sale and/or Maturity of Investments
84 74 119 227 93 69 104 96 149 128 114
Net Cash From Financing Activities
4.08 6.61 17 -4.67 4.90 4.41 12 9.59 8.09 2.02 -0.15
Net Cash From Continuing Financing Activities
4.08 6.61 17 -4.67 4.90 4.41 12 9.59 8.09 2.02 -0.15
Issuance of Common Equity
3.17 - 4.49 - 4.25 - 6.29 - 5.62 - 8.16
Other Financing Activities, net
0.92 6.61 12 -4.67 0.65 4.41 5.21 9.59 2.47 2.02 -8.31
Effect of Exchange Rate Changes
-0.12 0.23 -0.52 -0.29 0.12 -0.25 -0.03 0.80 0.26 0.23 -0.00

Annual Balance Sheets for JFrog

This table presents JFrog's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
238 689 853 871 973 1,130 1,341
Total Current Assets
199 653 499 532 646 649 873
Cash & Equivalents
39 164 68 46 85 50 76
Short-Term Investments
127 434 353 398 460 472 629
Accounts Receivable
25 37 50 62 76 91 120
Prepaid Expenses
5.36 14 22 19 13 20 26
Other Current Assets
2.35 3.25 5.27 8.10 11 16 22
Plant, Property, & Equipment, net
3.53 4.96 6.69 8.02 6.66 5.67 5.54
Total Noncurrent Assets
36 32 347 331 320 475 463
Goodwill
17 17 248 248 248 372 372
Intangible Assets
5.61 4.05 48 38 26 61 40
Other Noncurrent Operating Assets
13 10 51 46 46 43 51
Total Liabilities & Shareholders' Equity
238 689 853 871 973 1,130 1,341
Total Liabilities
96 135 214 246 293 356 454
Total Current Liabilities
86 123 175 210 262 318 408
Accounts Payable
13 31 39 15 17 11 14
Accrued Expenses
- - - 29 36 52 78
Current Deferred Revenue
73 92 129 159 201 247 310
Other Current Liabilities
- 0.00 7.29 7.13 8.27 7.79 5.78
Total Noncurrent Liabilities
9.63 13 39 37 31 39 46
Noncurrent Deferred Revenue
9.63 11 18 17 13 27 32
Other Noncurrent Operating Liabilities
0.00 1.55 21 20 18 12 14
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-33 554 639 625 679 774 887
Total Preferred & Common Equity
-33 554 639 625 679 774 887
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-33 554 639 625 679 774 887
Common Stock
32 628 777 857 969 1,133 1,313
Retained Earnings
-65 -75 -139 -229 -290 -360 -431
Accumulated Other Comprehensive Income / (Loss)
0.04 0.37 0.61 -2.77 1.01 0.66 5.77

Quarterly Balance Sheets for JFrog

This table presents JFrog's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
853 879 895 920 997 1,021 1,081 1,156 1,208 1,266 1,373
Total Current Assets
509 540 558 587 676 703 593 682 737 800 905
Cash & Equivalents
54 40 47 61 71 218 62 44 51 78 61
Short-Term Investments
380 407 423 441 508 373 406 519 560 573 680
Accounts Receivable
49 63 62 61 67 82 93 84 83 104 114
Prepaid Expenses
19 21 17 14 18 17 18 17 24 25 27
Other Current Assets
7.39 8.57 9.06 10 12 13 15 17 18 20 23
Plant, Property, & Equipment, net
8.05 7.48 7.03 6.58 6.47 6.53 6.05 5.54 5.72 5.69 6.50
Total Noncurrent Assets
336 331 330 326 315 311 481 469 465 460 462
Goodwill
248 248 248 248 248 248 371 372 372 372 372
Intangible Assets
41 35 32 29 23 20 67 55 49 45 35
Other Noncurrent Operating Assets
47 49 50 49 44 43 43 42 44 44 55
Total Liabilities & Shareholders' Equity
853 879 895 920 997 1,021 1,081 1,156 1,208 1,266 1,373
Total Liabilities
228 250 259 267 289 300 325 356 382 406 449
Total Current Liabilities
192 214 224 234 260 270 292 319 347 368 400
Accounts Payable
42 14 13 15 14 16 16 10 11 17 17
Accrued Expenses
- 29 32 32 40 40 44 51 68 62 67
Current Deferred Revenue
143 163 171 179 198 206 224 250 260 281 311
Other Current Liabilities
6.93 7.45 8.27 8.16 8.14 8.11 8.15 7.38 7.48 7.06 5.22
Total Noncurrent Liabilities
35 36 35 32 29 30 32 37 35 39 49
Noncurrent Deferred Revenue
17 16 13 12 13 16 20 25 22 28 30
Other Noncurrent Operating Liabilities
19 21 22 20 16 14 12 12 13 11 19
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
625 629 636 653 708 721 756 800 826 859 924
Total Preferred & Common Equity
625 629 636 653 708 721 756 800 826 859 924
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
625 629 636 653 708 721 756 800 826 859 924
Common Stock
835 881 905 936 1,007 1,037 1,092 1,179 1,221 1,270 1,362
Retained Earnings
-206 -250 -265 -279 -299 -314 -336 -378 -400 -416 -440
Accumulated Other Comprehensive Income / (Loss)
-4.24 -2.37 -3.48 -3.44 -0.14 -1.73 0.45 -1.22 5.74 5.55 2.25

Annual Metrics And Ratios for JFrog

This table displays calculated financial ratios and metrics derived from JFrog's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 64.82% 44.03% 37.03% 35.49% 24.94% 22.47% 24.12%
EBITDA Growth
0.00% 94.55% -394.89% -710.65% -26.95% 32.65% -11.64% 8.15%
EBIT Growth
0.00% 85.26% -222.54% -456.72% -25.32% 35.67% -20.74% -0.33%
NOPAT Growth
0.00% 74.17% -104.58% -381.74% -31.40% 15.91% -20.58% -0.83%
Net Income Growth
0.00% 79.27% -74.36% -582.65% -40.47% 32.08% -13.03% -3.73%
EPS Growth
0.00% 80.00% 0.00% -240.00% -33.82% 35.16% -6.78% 1.59%
Operating Cash Flow Growth
0.00% 16.84% 194.46% -5.28% -23.21% 246.11% 49.58% 31.38%
Free Cash Flow Firm Growth
0.00% 0.00% -47.14% -3,147.02% 91.27% 79.92% -3,240.49% 102.31%
Invested Capital Growth
0.00% 0.00% -83.47% 592.40% -16.50% -26.14% 87.54% -27.23%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 8.70% 6.59% 6.29% 4.59% 5.82%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -29.98% -1.14% 20.44% -17.03% 8.74%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -28.71% 0.79% 19.19% -19.76% 7.53%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -27.10% -2.56% 11.14% -12.38% 4.27%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -41.97% -0.51% 16.29% -20.89% 10.01%
EPS Q/Q Growth
0.00% 0.00% 0.00% -61.90% 1.09% 18.06% -21.15% 11.43%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 38.65% 21.01% -32.57% 51.72% 17.51% 1.09%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -160.33% 72.21% 6.73% -67.52%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -10.09% -4.89% -11.14% -12.79% -12.16%
Profitability Metrics
- - - - - - - -
Gross Margin
83.14% 80.87% 81.14% 79.76% 77.76% 77.98% 77.06% 76.79%
EBITDA Margin
-38.45% -1.27% -4.36% -25.82% -24.19% -13.04% -11.89% -8.79%
Operating Margin
-42.27% -6.62% -9.41% -33.08% -32.08% -21.59% -21.26% -17.27%
EBIT Margin
-40.21% -3.60% -8.05% -32.72% -30.26% -15.58% -15.36% -12.42%
Profit (Net Income) Margin
-40.95% -5.15% -6.24% -31.06% -32.20% -17.51% -16.16% -13.50%
Tax Burden Percent
101.84% 143.23% 77.43% 94.94% 106.42% 112.36% 105.19% 108.76%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% -55.23% -31.52% -33.50% -33.07% -29.59%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% -52.03% -25.20% -31.81% -32.05% -28.37%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 44.47% 17.24% 24.11% 23.54% 20.94%
Return on Equity (ROE)
0.00% -3.79% -2.70% -10.77% -14.28% -9.40% -9.53% -8.65%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% -142.32% -13.54% -3.44% -93.96% 1.93%
Operating Return on Assets (OROA)
0.00% -1.58% -2.62% -8.77% -9.83% -5.91% -6.26% -5.34%
Return on Assets (ROA)
0.00% -2.27% -2.03% -8.33% -10.46% -6.64% -6.59% -5.81%
Return on Common Equity (ROCE)
0.00% 0.89% -2.02% -10.77% -14.28% -9.40% -9.53% -8.65%
Return on Equity Simple (ROE_SIMPLE)
0.00% 16.13% -1.70% -10.05% -14.43% -9.02% -8.95% 0.00%
Net Operating Profit after Tax (NOPAT)
-19 -4.86 -9.93 -48 -63 -53 -64 -64
NOPAT Margin
-29.59% -4.64% -6.59% -23.16% -22.46% -15.11% -14.88% -12.09%
Net Nonoperating Expense Percent (NNEP)
0.00% -0.65% 0.14% -3.21% -6.32% -1.69% -1.02% -1.23%
Return On Investment Capital (ROIC_SIMPLE)
- - - - -10.07% -7.79% -8.24% -7.25%
Cost of Revenue to Revenue
16.86% 19.13% 18.86% 20.24% 22.24% 22.02% 22.94% 23.21%
SG&A Expenses to Revenue
29.66% 17.00% 22.89% 27.42% 19.84% 18.04% 16.34% 15.27%
R&D to Revenue
40.71% 28.39% 27.26% 38.52% 43.29% 38.47% 37.54% 36.68%
Operating Expenses to Revenue
125.41% 87.49% 90.55% 112.84% 109.84% 99.57% 98.32% 94.06%
Earnings before Interest and Taxes (EBIT)
-26 -3.77 -12 -68 -85 -55 -66 -66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-24 -1.33 -6.58 -53 -68 -46 -51 -47
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 10.34 4.48 3.42 5.35 4.24 8.33
Price to Tangible Book Value (P/TBV)
0.00 0.00 10.76 8.35 6.31 8.95 9.62 15.52
Price to Revenue (P/Rev)
8.01 4.86 37.99 13.85 7.64 10.38 7.66 13.89
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 11.23 9.34 23.00 10.97 36.53
Enterprise Value to Revenue (EV/Rev)
0.00 4.95 34.02 11.81 6.06 8.82 6.44 12.57
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 51.82 174.20 87.51 79.16 41.60 24.87 45.88
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 26.98 505.25 0.00 0.00 0.00 0.00 1,595.98
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.17 -1.10 -0.85 -0.68 -0.76 -0.73 -0.74
Leverage Ratio
0.00 1.67 1.33 1.29 1.36 1.41 1.45 1.49
Compound Leverage Factor
0.00 1.67 1.33 1.29 1.36 1.41 1.45 1.49
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 123.48% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -23.48% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 3.77 26.33 8.24 5.28 7.65 5.62 9.97
Noncontrolling Interest Sharing Ratio
0.00% 123.48% 25.25% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 2.31 5.32 2.85 2.54 2.46 2.04 2.14
Quick Ratio
0.00 2.22 5.18 2.69 2.41 2.37 1.93 2.02
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 19 10 -309 -27 -5.42 -181 4.19
Operating Cash Flow to CapEx
412.63% 554.85% 836.40% 659.93% 495.03% 3,741.42% 3,529.24% 4,211.82%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.44 0.33 0.27 0.32 0.38 0.41 0.43
Accounts Receivable Turnover
0.00 4.23 4.88 4.72 4.97 5.05 5.13 5.05
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 29.65 35.51 35.48 38.07 47.66 69.50 94.94
Accounts Payable Turnover
0.00 1.50 1.29 1.20 2.32 4.84 7.12 9.95
Days Sales Outstanding (DSO)
0.00 86.22 74.76 77.29 73.38 72.27 71.19 72.29
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 242.76 284.00 304.46 157.31 75.42 51.28 36.69
Cash Conversion Cycle (CCC)
0.00 -156.54 -209.25 -227.17 -83.93 -3.15 19.92 35.60
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 -24 -44 217 182 134 252 183
Invested Capital Turnover
0.00 -8.70 -4.42 2.39 1.40 2.22 2.22 2.45
Increase / (Decrease) in Invested Capital
0.00 -24 -20 262 -36 -47 117 -68
Enterprise Value (EV)
0.00 518 5,132 2,442 1,696 3,085 2,759 6,685
Market Capitalization
509 509 5,730 2,863 2,139 3,630 3,281 7,390
Book Value per Share
$0.00 ($1.23) $6.07 $6.62 $6.23 $6.47 $6.93 $7.50
Tangible Book Value per Share
$0.00 ($2.08) $5.84 $3.56 $3.38 $3.87 $3.06 $4.02
Total Capital
0.00 142 554 639 625 679 774 887
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -166 -598 -421 -443 -545 -522 -704
Capital Expenditures (CapEx)
2.08 1.80 3.52 4.23 4.33 1.98 3.14 3.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -54 -68 -97 -121 -161 -190 -239
Debt-free Net Working Capital (DFNWC)
0.00 113 530 324 322 384 332 465
Net Working Capital (NWC)
0.00 113 530 324 322 384 332 465
Net Nonoperating Expense (NNE)
7.22 0.54 -0.53 16 27 8.37 5.47 7.52
Net Nonoperating Obligations (NNO)
0.00 -166 -598 -421 -443 -545 -522 -704
Total Depreciation and Amortization (D&A)
1.12 2.44 5.57 14 17 8.90 15 19
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -51.14% -45.21% -47.11% -43.12% -46.12% -44.41% -44.92%
Debt-free Net Working Capital to Revenue
0.00% 107.84% 351.30% 156.64% 115.14% 109.64% 77.41% 87.52%
Net Working Capital to Revenue
0.00% 107.84% 351.30% 156.64% 115.14% 109.64% 77.41% 87.52%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($0.20) ($0.68) ($0.91) ($0.59) ($0.63) ($0.62)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 92.16M 97.38M 99.24M 103.32M 109.69M 116.20M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($0.20) ($0.68) ($0.91) ($0.59) ($0.63) ($0.62)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 92.16M 97.38M 99.24M 103.32M 109.69M 116.20M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($0.20) ($0.68) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 46.49M 94.78M 100.95M 106.31M 112.88M 119.63M
Normalized Net Operating Profit after Tax (NOPAT)
-19 -4.86 -9.93 -48 -63 -53 -64 -64
Normalized NOPAT Margin
-29.59% -4.64% -6.59% -23.16% -22.46% -15.11% -14.88% -12.09%
Pre Tax Income Margin
-40.21% -3.60% -8.05% -32.72% -30.26% -15.58% -15.36% -12.42%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for JFrog

This table displays calculated financial ratios and metrics derived from JFrog's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 119,628,931.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 119,628,931.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - -0.07
Growth Metrics
- - - - - - - - - - -
Revenue Growth
23.12% 27.06% 25.67% 22.42% 23.04% 19.35% 22.03% 23.46% 25.54% 25.18% 25.79%
EBITDA Growth
42.53% 62.63% 53.44% 13.80% -82.61% -105.98% -52.75% -43.79% 44.06% 31.10% 90.37%
EBIT Growth
44.19% 59.09% 50.32% 12.72% -96.60% -121.11% -78.08% -60.81% 38.41% 27.10% 66.02%
NOPAT Growth
22.99% 38.12% 28.33% -1.16% -65.76% -65.27% -38.07% -35.78% 27.84% 16.10% 43.70%
Net Income Growth
41.63% 51.49% 57.76% 7.53% -66.91% -106.52% -110.50% -51.54% 28.39% 34.43% 55.32%
EPS Growth
45.83% 56.52% 61.90% 13.33% -61.54% -110.00% -100.00% -46.15% 33.33% 38.10% 56.25%
Operating Cash Flow Growth
406.65% 345.62% 1,647.30% -0.08% 6.39% 50.70% 64.82% 116.12% 9.11% 3.21% 33.22%
Free Cash Flow Firm Growth
-20.78% 98.53% 286.37% 41.73% -679.09% -468.43% -396.71% -555.10% 140.99% 139.62% 135.95%
Invested Capital Growth
-20.95% -26.14% -29.48% -21.66% 91.11% 87.54% 84.52% 65.05% -27.76% -27.23% -22.74%
Revenue Q/Q Growth
5.31% 9.73% 3.14% 2.72% 5.84% 6.44% 5.45% 3.93% 7.61% 6.13% 5.97%
EBITDA Q/Q Growth
13.32% 31.43% -10.94% -30.72% -83.64% 22.65% 17.73% -23.05% 28.56% 4.74% 88.50%
EBIT Q/Q Growth
12.09% 27.20% -6.49% -28.07% -98.01% 18.12% 14.23% -15.65% 24.17% 3.08% 60.02%
NOPAT Q/Q Growth
4.53% 14.80% -8.18% -14.97% -56.43% 15.06% 9.62% -13.06% 16.87% 1.24% 39.35%
Net Income Q/Q Growth
11.12% 18.29% 21.75% -62.72% -60.42% -1.10% 20.24% -17.14% 24.19% 7.43% 45.65%
EPS Q/Q Growth
13.33% 23.08% 20.00% -62.50% -61.54% 0.00% 23.81% -18.75% 26.32% 7.14% 46.15%
Operating Cash Flow Q/Q Growth
55.48% 25.45% -46.40% -4.42% 65.54% 77.71% -41.38% 25.33% -16.43% 68.10% -24.34%
Free Cash Flow Firm Q/Q Growth
71.65% 34.12% 14.27% -46.12% -801.32% 14.67% 7.97% 17.36% 163.17% -17.53% -16.50%
Invested Capital Q/Q Growth
-9.14% -11.14% -4.42% 1.50% 121.66% -12.79% -5.96% -9.21% -2.98% -12.16% -0.15%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
77.72% 79.00% 79.46% 78.75% 74.98% 75.44% 75.34% 76.26% 77.43% 77.86% 78.18%
EBITDA Margin
-11.51% -7.19% -7.73% -9.84% -17.08% -12.41% -9.68% -11.46% -7.61% -6.83% -0.74%
Operating Margin
-20.36% -15.81% -16.58% -18.56% -27.44% -21.89% -18.77% -20.41% -15.77% -14.67% -8.40%
EBIT Margin
-13.90% -9.22% -9.52% -11.87% -22.20% -17.08% -13.89% -15.46% -10.89% -9.95% -3.75%
Profit (Net Income) Margin
-15.51% -11.55% -8.76% -13.88% -21.04% -19.98% -15.12% -17.04% -12.00% -10.47% -5.37%
Tax Burden Percent
111.61% 125.27% 92.05% 116.96% 94.76% 117.00% 108.81% 110.22% 110.18% 105.24% 143.05%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-27.45% -24.53% -27.74% -34.15% -35.82% -34.06% -32.46% -39.34% -22.34% -25.14% -15.80%
ROIC Less NNEP Spread (ROIC-NNEP)
-27.22% -24.44% -28.30% -33.98% -35.40% -33.05% -32.03% -38.76% -22.10% -25.10% -15.92%
Return on Net Nonoperating Assets (RNNOA)
19.94% 18.52% 21.74% 26.56% 24.37% 24.27% 24.28% 30.13% 15.31% 18.53% 12.05%
Return on Equity (ROE)
-7.52% -6.01% -6.01% -7.59% -11.45% -9.79% -8.17% -9.22% -7.03% -6.61% -3.75%
Cash Return on Invested Capital (CROIC)
-11.42% -3.44% 3.42% -8.41% -88.42% -93.96% -96.81% -91.41% 5.19% 1.93% -1.67%
Operating Return on Assets (OROA)
-5.16% -3.50% -3.76% -4.82% -9.09% -6.96% -5.81% -6.58% -4.67% -4.28% -1.67%
Return on Assets (ROA)
-5.76% -4.38% -3.46% -5.64% -8.62% -8.15% -6.33% -7.26% -5.14% -4.51% -2.39%
Return on Common Equity (ROCE)
-7.52% -6.01% -6.01% -7.59% -11.45% -9.79% -8.17% -9.22% -7.03% -6.61% -3.75%
Return on Equity Simple (ROE_SIMPLE)
-11.20% 0.00% -6.96% -6.66% -7.57% 0.00% -9.87% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-13 -11 -12 -13 -21 -18 -16 -18 -15 -15 -9.05
NOPAT Margin
-14.25% -11.07% -11.61% -12.99% -19.20% -15.33% -13.14% -14.29% -11.04% -10.27% -5.88%
Net Nonoperating Expense Percent (NNEP)
-0.24% -0.09% 0.56% -0.17% -0.41% -1.01% -0.42% -0.58% -0.24% -0.05% 0.12%
Return On Investment Capital (ROIC_SIMPLE)
- -1.59% - - - -2.30% -2.01% -2.20% -1.76% -1.68% -0.98%
Cost of Revenue to Revenue
22.28% 21.00% 20.54% 21.25% 25.02% 24.56% 24.66% 23.74% 22.57% 22.14% 21.82%
SG&A Expenses to Revenue
17.67% 19.02% 16.89% 16.75% 16.26% 15.58% 15.56% 15.83% 14.95% 14.85% 15.42%
R&D to Revenue
37.63% 33.72% 35.72% 36.02% 39.43% 38.70% 35.40% 37.28% 37.37% 36.59% 33.65%
Operating Expenses to Revenue
98.08% 94.81% 96.04% 97.32% 102.41% 97.33% 94.11% 96.67% 93.20% 92.53% 86.58%
Earnings before Interest and Taxes (EBIT)
-12 -8.97 -9.55 -12 -24 -20 -17 -20 -15 -14 -5.78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-10 -6.99 -7.76 -10 -19 -14 -12 -15 -10 -9.92 -1.14
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
4.03 5.35 6.55 5.64 4.24 4.24 4.51 6.08 6.43 8.33 6.08
Price to Tangible Book Value (P/TBV)
6.99 8.95 10.61 8.98 10.08 9.62 9.67 12.39 12.46 15.52 10.85
Price to Revenue (P/Rev)
8.00 10.38 12.52 10.46 7.83 7.66 8.02 10.59 10.99 13.89 9.96
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
14.11 23.00 31.66 26.74 9.50 10.97 12.89 20.56 23.39 36.53 26.66
Enterprise Value to Revenue (EV/Rev)
6.47 8.82 10.96 8.94 6.69 6.44 6.77 9.30 9.70 12.57 8.65
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
43.58 41.60 43.76 37.52 29.01 24.87 24.94 31.18 33.81 45.88 31.38
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 766.00 0.00 0.00 0.00 0.00 0.00 377.92 1,595.98 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.73 -0.76 -0.77 -0.78 -0.69 -0.73 -0.76 -0.78 -0.69 -0.74 -0.76
Leverage Ratio
1.39 1.41 1.40 1.41 1.42 1.45 1.43 1.44 1.45 1.49 1.47
Compound Leverage Factor
1.39 1.41 1.40 1.41 1.42 1.45 1.43 1.44 1.45 1.49 1.47
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
6.27 7.81 10.04 8.57 6.13 5.75 6.34 8.17 8.47 10.09 7.89
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.51 2.46 2.60 2.61 2.03 2.04 2.14 2.13 2.18 2.14 2.26
Quick Ratio
2.40 2.37 2.48 2.50 1.92 1.93 2.03 2.00 2.06 2.02 2.14
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
27 37 42 23 -158 -135 -124 -103 65 54 45
Operating Cash Flow to CapEx
4,396.11% 5,273.95% 2,077.17% 2,281.01% 2,952.99% 7,747.32% 4,450.08% 5,755.18% 2,240.49% 6,035.12% 3,584.67%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.37 0.38 0.39 0.41 0.41 0.41 0.42 0.43 0.43 0.43 0.45
Accounts Receivable Turnover
5.99 5.05 5.71 5.39 5.33 5.13 5.97 5.75 5.10 5.05 5.69
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
44.99 47.66 53.08 57.42 64.86 69.50 75.00 77.52 85.60 94.94 93.54
Accounts Payable Turnover
2.60 4.84 5.59 5.64 5.82 7.12 8.82 8.45 7.15 9.95 9.45
Days Sales Outstanding (DSO)
60.96 72.27 63.94 67.77 68.52 71.19 61.11 63.45 71.64 72.29 64.14
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
140.27 75.42 65.27 64.72 62.70 51.28 41.40 43.17 51.04 36.69 38.63
Cash Conversion Cycle (CCC)
-79.30 -3.15 -1.34 3.04 5.82 19.92 19.70 20.28 20.60 35.60 25.51
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
151 134 128 130 288 252 237 215 208 183 183
Invested Capital Turnover
1.93 2.22 2.39 2.63 1.86 2.22 2.47 2.75 2.02 2.45 2.69
Increase / (Decrease) in Invested Capital
-40 -47 -54 -36 138 117 108 85 -80 -68 -54
Enterprise Value (EV)
2,130 3,085 4,058 3,480 2,739 2,759 3,049 4,416 4,874 6,685 4,873
Market Capitalization
2,632 3,630 4,638 4,071 3,207 3,281 3,612 5,027 5,525 7,390 5,614
Book Value per Share
$6.29 $6.47 $6.61 $6.65 $6.85 $6.93 $7.09 $7.21 $7.36 $7.50 $7.72
Tangible Book Value per Share
$3.63 $3.87 $4.08 $4.18 $2.88 $3.06 $3.31 $3.54 $3.80 $4.02 $4.32
Total Capital
653 679 708 721 756 774 800 826 859 887 924
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-502 -545 -580 -591 -468 -522 -564 -612 -651 -704 -741
Capital Expenditures (CapEx)
0.59 0.62 0.84 0.73 0.94 0.63 0.65 0.63 1.35 0.84 1.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-149 -161 -164 -158 -167 -190 -201 -221 -219 -239 -237
Debt-free Net Working Capital (DFNWC)
353 384 415 433 301 332 363 390 433 465 505
Net Working Capital (NWC)
353 384 415 433 301 332 363 390 433 465 505
Net Nonoperating Expense (NNE)
1.11 0.47 -2.86 0.91 2.00 5.41 2.42 3.50 1.32 0.28 -0.78
Net Nonoperating Obligations (NNO)
-502 -545 -580 -591 -468 -522 -564 -612 -651 -704 -741
Total Depreciation and Amortization (D&A)
2.12 1.97 1.79 2.09 5.59 5.42 5.16 5.08 4.50 4.53 4.64
Debt-free, Cash-free Net Working Capital to Revenue
-45.37% -46.12% -44.34% -40.57% -40.67% -44.41% -44.50% -46.60% -43.47% -44.92% -41.99%
Debt-free Net Working Capital to Revenue
107.19% 109.64% 112.16% 111.34% 73.51% 77.41% 80.56% 82.25% 86.06% 87.52% 89.57%
Net Working Capital to Revenue
107.19% 109.64% 112.16% 111.34% 73.51% 77.41% 80.56% 82.25% 86.06% 87.52% 89.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.13) ($0.10) ($0.08) ($0.13) ($0.21) ($0.21) ($0.16) ($0.19) ($0.14) ($0.13) ($0.07)
Adjusted Weighted Average Basic Shares Outstanding
104.13M 103.32M 107.03M 108.94M 110.77M 109.69M 113.45M 115.25M 117.26M 116.20M 120.16M
Adjusted Diluted Earnings per Share
($0.13) ($0.10) ($0.08) ($0.13) ($0.21) ($0.21) ($0.16) ($0.19) ($0.14) ($0.13) ($0.07)
Adjusted Weighted Average Diluted Shares Outstanding
104.13M 103.32M 107.03M 108.94M 110.77M 109.69M 113.45M 115.25M 117.26M 116.20M 120.16M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
104.89M 106.31M 108.42M 110.42M 111.56M 112.88M 114.57M 116.74M 118.31M 119.63M 121.12M
Normalized Net Operating Profit after Tax (NOPAT)
-13 -11 -12 -13 -21 -18 -16 -18 -15 -15 -9.05
Normalized NOPAT Margin
-14.25% -11.07% -11.61% -12.99% -19.20% -15.33% -13.14% -14.29% -11.04% -10.27% -5.88%
Pre Tax Income Margin
-13.90% -9.22% -9.52% -11.87% -22.20% -17.08% -13.89% -15.46% -10.89% -9.95% -3.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

JFrog Ltd (NASDAQ: FROG) has shown revenue growth and improving cash flow in 2025, but remains unprofitable on a quarterly basis and continues to invest heavily in investments and growth initiatives. Below are the key trends from the last four years of quarterly data, with positives listed first, then neutral observations, then negatives.

  • Revenue growth in 2025: Q4 2025 operating revenue was $145,306,000, up from $116,078,000 in Q4 2024 (about +25% YoY).
  • Gross margin remains strong: Total Gross Profit in Q4 2025 was $113,136,000 on $145,306,000 of revenue (roughly 77.6% gross margin).
  • Solid operating cash flow generation: In Q4 2025, net cash from continuing operating activities was $50,695,000; four-quarter 2025 net cash from continuing operating activities totaled about $145.7 million.
  • Earnings per share trajectory improving: Q4 2025 Basic and Diluted EPS were -$0.13, a narrower loss than earlier in 2025 (e.g., -$0.19 in some prior quarters), indicating an improving loss trajectory.
  • R&D and marketing remain large, ongoing investments: Q4 2025 RD expense was about $53.163 million and marketing expense about $59.720 million, contributing to total operating expenses of roughly $134.458 million.
  • Substantial cash deployment into investments: Purchase of Investments in 2025 quarters were sizable (Q4 2025: ~ $182.65 million; Q3: ~ $159.08 million; Q2: ~ $135.17 million; Q1: ~ $149.08 million), reflecting portfolio deployment rather than immediate profitability.
  • Leverage is moderate but rising liabilities: By Q3 2025, Total Liabilities were about $406.1 million and Total Equity around $859.4 million, implying a debt-to-equity stance roughly 0.47x.
  • Ongoing net losses: Net income attributable to common shareholders remained negative in 2025, with Q4 2025 net income about $-15.21 million and EPS around -$0.13.
  • Operating losses persist: Total Operating Income in Q4 2025 was about $-21.32 million, indicating the core business remains unprofitable on an operating basis.
  • Investing cash outflows depress liquidity: Net cash from investing activities in Q4 2025 was approximately $-55.5 million, driven by substantial purchases of investments and other long-term assets.
05/14/26 03:43 PM ETAI Generated. May Contain Errors.

JFrog Financials - Frequently Asked Questions

According to the most recent income statement we have on file, JFrog's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

JFrog's net income appears to be on an upward trend, with a most recent value of -$71.82 million in 2025, rising from -$26.02 million in 2018. The previous period was -$69.24 million in 2024. See where experts think JFrog is headed by visiting JFrog's forecast page.

JFrog's total operating income in 2025 was -$91.85 million, based on the following breakdown:
  • Total Gross Profit: $408.39 million
  • Total Operating Expenses: $500.24 million

Over the last 7 years, JFrog's total revenue changed from $63.53 million in 2018 to $531.84 million in 2025, a change of 737.1%.

JFrog's total liabilities were at $453.93 million at the end of 2025, a 27.4% increase from 2024, and a 374.7% increase since 2019.

In the past 6 years, JFrog's cash and equivalents has ranged from $39.15 million in 2019 to $164.46 million in 2020, and is currently $75.84 million as of their latest financial filing in 2025.

Over the last 7 years, JFrog's book value per share changed from 0.00 in 2018 to 7.50 in 2025, a change of 750.1%.



Financial statements for NASDAQ:FROG last updated on 5/13/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners